The glucagon receptor component, which increases energy expenditure and lipolysis, may theoretically produce metabolic effects in non-obese populations, but safety and efficacy data are absent
Retatrutide + a myostatin inhibitorthe holy grail GLP-1 Retatrutide hasnt even been approved, yet a jaw-dropping twist is already in the works
And we all need to challenge our balance [00:47:00] because listen, if you're listening to this podcast, you better not, you better not have a hip fracture, uh, because it is seriously, one of my goals with this podcast is that I, I'm not blaming you if you do, but one of my goals is to make sure that women know you need to build muscle and you need to work on balance because we wanna avoid hip fractures
Unlike national quick-fix companies, we focus on education, safety, and long-term success